Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues PG Q1 2026 Earnings EPS Slightly Misses Estimates Stock Gains 317 IT Q1 2026 Earnings Strong EPS Beat Bolsters Investor Confidence CYH Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges WHLRL Q2 2024 Earnings Unanticipated EPS Surge Amid Limited Disclosure Amicus Therapeutics Q4 2025 Earnings EPS Misses Expectations by a Wide Margin